These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20511607)

  • 1. ANA screening: an old test with new recommendations.
    Meroni PL; Schur PH
    Ann Rheum Dis; 2010 Aug; 69(8):1420-2. PubMed ID: 20511607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases.
    Tozzoli R; Bizzaro N; Tonutti E; Villalta D; Bassetti D; Manoni F; Piazza A; Pradella M; Rizzotti P;
    Am J Clin Pathol; 2002 Feb; 117(2):316-24. PubMed ID: 11863229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
    Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
    Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basics in standardization and practical applications of immunofluorescent microscopy: standardization of antinuclear antibody tests.
    Beutner EH; Kumar V; Greenlee P
    Lab Res Methods Biol Med; 1983; 8():49-70. PubMed ID: 6358746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinuclear antibodies: clinical applications.
    Wanchu A
    J Postgrad Med; 2000; 46(2):144-8. PubMed ID: 11013488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus.
    Jearn LH; Kim DA; Kim TY
    J Rheumatol; 2009 Aug; 36(8):1833-4. PubMed ID: 19671822
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases.
    Ghillani P; Rouquette AM; Desgruelles C; Hauguel N; Le Pendeven C; Piette JC; Musset L
    Ann N Y Acad Sci; 2007 Aug; 1109():407-13. PubMed ID: 17785329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody determination in the diagnosis of systemic lupus erythematosus.
    Kurien BT; Scofield RH
    Scand J Immunol; 2006 Sep; 64(3):227-35. PubMed ID: 16918691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.
    Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
    J Assoc Physicians India; 2004 Apr; 52():290-3. PubMed ID: 15636329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretative comments on autoantibody tests.
    Tonutti E; Visentini D; Bizzaro N
    Autoimmun Rev; 2007 Jun; 6(6):341-6. PubMed ID: 17537378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting.
    Narain S; Richards HB; Satoh M; Sarmiento M; Davidson R; Shuster J; Sobel E; Hahn P; Reeves WH
    Arch Intern Med; 2004 Dec 13-27; 164(22):2435-41. PubMed ID: 15596633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Traditional and innovative diagnostic tools: when and why they should be applied].
    Cancrini G; Iori A
    Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of some immunoserologic diagnostic tests in systemic diseases.
    Rozman B; Kveder T; Lestan B
    Acta Med Austriaca; 1988; 15(5):148-9. PubMed ID: 3265251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding antinuclear antibodies.
    Pertusi RM; Rubin BR
    J Am Osteopath Assoc; 1991 Jun; 91(6):563-4, 567-9. PubMed ID: 1874653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic autoimmune rheumatic diseases in 2013: problems of laboratory diagnosis].
    Nasonov EL; Aleksandrova EN; Novikov AA
    Ter Arkh; 2014; 86(5):4-9. PubMed ID: 25026796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines take shape on ANA, gammopathy testing.
    Check I
    CAP Today; 1998 Aug; 12(8):16-20, 24-5. PubMed ID: 10182651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.